Role of flow cytometry in the assessment of restoration of hematopoiesis during standard Exjade® treatment in patients with low- intermediate I risk myelodysplastisc syndromes, a pilot study
Completed
- Conditions
- n.a.10018849
- Registration Number
- NL-OMON35738
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
MDS type low and intermediate risk, supportive care treatment, start Exjade®
Exclusion Criteria
Comorbidity, anaemia MDS unrelated, previous treatment with Exjade®
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>see above</p><br>
- Secondary Outcome Measures
Name Time Method <p>See above</p><br>